CPT code 53865 represents a minimally invasive cystoscopic procedure that places a temporary device into the prostatic urethra to compress tissue and induce ischemia, aiming to relieve urethral obstruction and improve urinary flow. This code captures a targeted endoscopic approach used in select patients with prostatic-related lower urinary tract symptoms; nationally, its use factors into procedural coding, coverage determinations, and outpatient surgical workflows.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and service context, an outline of payer coverage considerations, and guidance on where to look for benchmarks and policy updates. The material addresses typical sites of service (ambulatory surgical centers and hospital outpatient departments) and the procedural nature of the service, useful for coding staff, billing analysts, and clinical program managers.

This publication provides an executive-level summary of the code’s purpose and operational setting, summarizes what clinicians and coders should know about reporting the service, and identifies areas where readers may need to consult payer-specific policies or clinical guidelines. Data not available in the input.